Dr. Gunter is Reader in Cancer Epidemiology and Prevention in the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College. He is a molecular epidemiologist and his main research focus is the role of metabolic and endocrine pathways in cancer development and prognosis.
Examples of current research projects include:
- Metabolomic Profiling and Colorectal Cancer Development
- Steroid hormones, insulin and insulin-like growth factors in endometrial cancer prognosis
- Diabetes and Cancer Initiative
- Improving clinical endpoint definitions for epidemiologic studies in the BBMRI-LPC partnership
Dr Gunter is a co-investigator of the European Prospective Investigation into Cancer (EPIC)
Dr Gunter is co-director of the MSc in Epidemiology and leads modules on Principles and Methods of Epidemiology and Molecular Epidemiology. Dr Gunter is also an executive board member of the MRC-PHE Centre for Environment & Health and oversees the centre training programme
Dr Gunter is an editor for Cancer Research and a peer reviewer for numerous other scientific and medical journals
Education and Professional Employment
Oct 1994-July 1998 University of Oxford, B.A. Hons. Biochemistry
Oct 1998-May 2003 University of Cambridge, Ph.D. Molecular Epidemiology
Dec 2003-Dec 2005 National Cancer Institute, NIH, DHHS, USA; Post-doctoral fellow, Division of Cancer Epidemiology and Genetics
Dec 2005-Aug 2011 Albert Einstein College of Medicine, New York, USA; Department of Epidemiology and Population Health; 2005-2007, Instructor; 2007-2011, Assistant Professor
Sep 2011- Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health; Reader in Cancer Epidemiology.